3529 POSTER Effect of Sample Type and Turnaround Time (TAT) on the Feasibility of Non-Small Cell Lung Cancer (NSCLC) Epidermal Growth Factor Receptor (EGFR) Mutation Testing in Routine Clinical Practice: Results From the Spanish REASON Study

M. Gracia, M. Majem, M.T. Martinez Aguillo, N. Martinez Banaclocha, M. Provencio, E. Arriola, M. Codes, A. Artal, R. Cajal, B. Massuti Sureda. Hospital Universitario Central de Asturias, Medical Oncology, Oviedo, Spain; Hospital de la Santa Creu i Sant Pau, Medical Oncology, Barcelona, Spain; Hospital de Navarra, Medical Oncology, Pamplona, Spain; Hospital General Universitario de Elche, Medical Oncology, Alicante, Spain; Hospital Universitario Puerta de Hierro de Majadahonda, Medical Oncology, Madrid, Spain; Hospital del Mar, Medical Oncology, Barcelona, Spain; Hospital Virgen de la Macarena, Medical Oncology, Sevilla, Spain; Hospital Universitario Miguel Servet, Medical Oncology, Zaragoza, Spain; AstraZeneca Farmaceutica Spain, Medical, Madrid, Spain; Hospital General Universitario de Alicante, Medical Oncology, Alicante, Spain